Our Take: New Cholesterol Guidelines

From eNewsletter April 1, 2026

DID YOU KNOW that according to a Cochrane Reviews, daily aspirin does not reliably prevent bowel cancer in people at average risk?

Any potential protective effect may take more than a decade to appear, if it appears at all, and the evidence for that benefit is weak. In contrast, the risk of serious bleeding begins right away, even with low-dose aspirin. Experts warn that prevention decisions should be individualized, not automatic.

To read the rest of today's email, please go to this page.